I'd be OK with a suitably high TO bid based on MND being blockbuster, but which accounts for some of the cancer patents.
By suitably high I mean $1 to $3 per share.
Would also be happy if they sold off nuerodegenerative patents separately for similar and the cash is divided into special dividend, while other pipelines are progressed.
Call me impatient but if we have a saleable product shortly, that can be sold for FAIR value, then do it. Be nice to enjoy the fruits this decade.
Full takeover versus multiple deals?, page-2
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.010(4.35%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.5¢ | 22.0¢ | $111.9K | 495.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 128392 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 48891 | 4 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
22.5¢ |
Change
-0.010 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 23.5¢ | 23.5¢ | 22.0¢ | 221305 | ||
| Last updated 15.23pm 02/05/2024 ? | |||||
| PAA (ASX) Chart |